PodcastOne (Nasdaq: PODC) Appoints Wall Street Veteran Jon Merriman to Its Board of Directors
LOS ANGELES, May 31, 2024 (GLOBE NEWSWIRE) — PodcastOne (NASDAQ: PODC), a leading podcast platform and a subsidiary of LiveOne […]
Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference
MONTREAL and CHARLOTTE, N.C., May 31, 2024 (GLOBE NEWSWIRE) — Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that members of its […]
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus
Clinical testing of LP-310 expected to commence in mid-2024 Patient recruitment is underway for Phase 2a multicenter, dose-ranging study PITTSBURGH, […]
Iterum Therapeutics Receives FDA Acceptance of Resubmission of NDA for Oral Sulopenem for the treatment of Uncomplicated Urinary Tract Infections
DUBLIN and CHICAGO, May 31, 2024 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company […]
FOREWARN Partners with Santa Barbara Multiple Listing Service
BOCA RATON, Fla., May 31, 2024 (GLOBE NEWSWIRE) — FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading […]
TSX News -
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
SAN DIEGO and TORONTO, May 31, 2024 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: […]
Solar Alliance reports profitable Q1 result supported by 70% year-over-year revenue increase
TORONTO and KNOXVILLE, Tenn., May 31, 2024 (GLOBE NEWSWIRE) — Solar Alliance Energy Inc. (‘Solar Alliance’ or the ‘Company’) (TSX-V: […]
ABM Named Among Barron’s 100 Most Sustainable Companies for Second Consecutive Year
NEW YORK, May 31, 2024 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of integrated facility services, infrastructure solutions, […]
Li Auto Inc. Announces Results of Annual General Meeting
BEIJING, China, May 31, 2024 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), […]
Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
SEATTLE, May 31, 2024 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to […]
